Bindwell

We use AI to build better pesticides.

Website: https://bindwell.ai/

Cover Block

PUBLIC

Field Value
Name Bindwell
Tagline "We use AI to build better pesticides."
Headquarters San Francisco, California
Founded 2024
Stage Seed
Business Model B2B
Industry Agtech
Technology AI / Machine Learning
Geography North America
Growth Profile Venture Scale
Founding Team Co-Founders (2)
Funding Label Seed
Total Disclosed ~$6,000,000

Links

PUBLIC

Executive Summary

PUBLIC

Bindwell is a San Francisco-based agtech startup applying foundation-model techniques from AI drug discovery to the design of new pesticide molecules, and it has quickly drawn the kind of investor list that is uncommon for a company barely a year old [TechCrunch, Nov 2025]. The company was founded in 2024 by Tyler Rose and Navvye Anand, who met at the Wolfram Summer Research Program in 2023 and were 18 and 19, respectively, when they started the company [TechCrunch, Nov 2025] [Ventureport]. Both subsequently left formal education (Rose from high school, Anand from Caltech) to build Bindwell full time [Forbes] [Bindwell website]. The technical premise, articulated on the company's own blog, is that general-purpose models trained on large molecular datasets will outperform human-curated, hypothesis-led discovery pipelines for identifying candidate active ingredients [Bindwell blog]. Bindwell was accepted into Y Combinator's Winter 2025 batch [El Estoque, Jan 2025] and announced a roughly $6 million seed round whose participants include Paul Graham, General Catalyst, A Capital, and SV Angel [TechCrunch, Nov 2025] [Rowan]. The business is positioned as a B2B platform for pesticide R&D rather than a direct-to-grower brand [Y Combinator]. Over the next 12 to 18 months, the watch items are whether Bindwell publishes peer-reviewable benchmarks beyond the open-source PLAPT model already on its GitHub, whether it discloses named agrochemical design partners, and whether the seed proceeds carry it to a validated lead molecule.

Data Accuracy: GREEN -- Confirmed by TechCrunch, Y Combinator, Forbes, and the company's own site.

Taxonomy Snapshot

Axis Value
Stage Seed
Business Model B2B
Industry / Vertical Agtech / Crop Protection
Technology Type AI / Machine Learning (foundation models for molecular design)
Geography North America (San Francisco HQ)
Growth Profile Venture Scale
Founding Team Two technical co-founders
Funding ~$6M seed disclosed [TechCrunch, Nov 2025]

Company Overview

PUBLIC

Bindwell traces its origin to a 2023 summer at Wolfram Research, where Tyler Rose and Navvye Anand met as participants in the Wolfram Summer Research Program [Ventureport]. The two stayed in contact and, in 2024, formalized the company around a thesis that the same machine-learning architectures driving progress in protein-ligand prediction and small-molecule drug discovery could be retargeted at agrochemicals, a category they argue has lagged pharma in computational sophistication [Bindwell blog] [TechCrunch, Nov 2025]. Rose, who is listed on the company website as CEO, previously worked at Wolfram Research and has been recognized on the Forbes 30 Under 30 science list; Anand, formerly at Caltech, leads alongside him as co-founder [Bindwell website] [LinkedIn]. Both founders were named to the Forbes 30 Under 30 2026 list [Forbes, 2026].

The company's first major external milestone was acceptance into Y Combinator's Winter 2025 cohort, reported in January 2025 by Tyler Rose's high school newspaper and confirmed on the YC company directory [El Estoque, Jan 2025] [Y Combinator]. In November 2025, TechCrunch reported that the company had raised approximately $6 million in seed financing with participation from Paul Graham, General Catalyst, A Capital, and SV Angel [TechCrunch, Nov 2025], a syndicate also referenced in Rowan's interview with Anand around the same period [Rowan]. The structured facts available do not name a single lead investor for the round.

Bindwell operates from San Francisco, maintains a GitHub organization that hosts its open-source PLAPT protein-ligand binding-affinity model [GitHub], and runs a small merchandise storefront on a separate subdomain. The founders have publicly framed the mission as transforming the agrochemical industry through computational discovery rather than incremental chemistry [Bindwell website].

Data Accuracy: GREEN -- Confirmed by TechCrunch, Y Combinator, Forbes, and the company's own website.

Product and Technology

MIXED

Bindwell describes itself as an AI platform for pesticide R&D [Y Combinator] [PUBLIC]. The company's technical blog frames its approach in reference to Rich Sutton's "bitter lesson" essay, arguing that "general methods that use computation are ultimately the most effective" and that foundation models trained on large molecular datasets are preferable to hypothesis-driven, human-curated screens for finding new active ingredients [Bindwell blog] [PUBLIC]. In practice, this means models that propose and rank candidate small molecules and proteins for further wet-lab testing rather than software that itself synthesizes compounds.

The most concrete public artifact of the platform is PLAPT, a protein-ligand binding-affinity model published on the company's GitHub organization with a Python package and command-line interface [GitHub] [PUBLIC]. A third-party product directory, HuntScreens, describes Bindwell's platform as "up to 30% more accurate than existing models, screening 700,000 molecules per second," with Python, CLI, and web-based interfaces [HuntScreens] [PUBLIC]. Those throughput and accuracy figures have not, in the sources reviewed here, been independently benchmarked in a peer-reviewed venue, so they are best read as the company's own performance claim rather than a settled result. TechCrunch's November 2025 coverage characterizes the work as adapting AI-led drug discovery techniques to agriculture in order to speed up the identification and testing of new pesticide molecules [TechCrunch, Nov 2025] [PUBLIC].

What is not publicly disclosed is equally informative for diligence: the company has not, in the sources captured, named a specific agrochemical partner, disclosed a lead candidate molecule, or published a regulatory milestone with the EPA or any equivalent body. The business model is described as B2B, which is consistent with a discovery-platform-to-incumbent licensing or co-development structure, but the contracting model itself is not publicly detailed.

Data Accuracy: YELLOW -- Core technology framing confirmed by company blog, GitHub, and TechCrunch; specific performance claims rest on a single third-party directory listing and the company's own statements.

Market Research and Opportunity

PUBLIC

Crop protection sits at the intersection of two slow-moving forces, regulatory tightening and pest resistance, that together are pushing the agrochemical industry toward novel chemistries on a faster cycle than the historic 10-plus-year discovery timeline can support. Bindwell's pitch lands inside that gap.

Bindwell has not, in the structured facts available, cited a specific TAM figure from a named third-party report, and this analysis will not invent one. What can be said from primary reporting is directional: TechCrunch's November 2025 piece frames the company's strategy as importing methods from pharmaceutical AI discovery into agriculture, a category where development costs and timelines have historically tracked drug discovery without the corresponding investment in computational tooling [TechCrunch, Nov 2025]. The founders' own framing on the Bindwell blog argues that the field has been bottlenecked by human-curated chemistry rather than by data or compute [Bindwell blog].

Demand-side tailwinds are easier to identify qualitatively than to size from the cited research. Resistance to existing modes of action, the phased withdrawal of older actives by regulators in the EU and parts of Asia, and the growing premium on biologically selective chemistries that spare pollinators all push agrochemical majors toward refreshed pipelines. The adjacent and substitute markets are also active: biologicals, RNA-interference products, and precision-application hardware all compete for the same R&D dollar. None of those substitutes is named in the structured facts captured here, and Bindwell has not publicly positioned against any of them.

The regulatory layer is the single most important macro variable. Pesticide registration in the United States runs through the EPA under FIFRA, with multi-year data packages, and analogous regimes in the EU and major agricultural exporters add cost and time. An AI-discovery platform compresses the front end of that pipeline (hit identification, lead optimization) but does not shorten the regulatory tail, which is a structural ceiling on how much of the value chain a company like Bindwell can capture without a development partner.

Cited claim Figure Source
Disclosed seed round ~$6,000,000 [TechCrunch, Nov 2025]
Platform screening throughput (company claim) 700,000 molecules / second [HuntScreens]
Platform accuracy uplift (company claim) up to 30% vs. existing models [HuntScreens]

The takeaway: the available numbers describe the company's stated capability and capitalization, not the size of the prize. Investors evaluating Bindwell will need to source their own market sizing from a named agrochemical industry report rather than relying on figures in the public record around the company.

Data Accuracy: YELLOW -- Market framing supported by TechCrunch and the company blog; no third-party TAM citation is available in the captured sources.

Competitive Landscape

MIXED

No direct competitors are named in the structured facts for Bindwell, which means the competitive picture has to be drawn by category rather than by head-to-head comparison.

The relevant arena has at least three layers. The first is the global crop-protection incumbents, the handful of multinational agrochemical companies that own existing actives, distribution into growers, and the regulatory dossiers required to bring a new molecule to market. None of these incumbents is named in the captured sources as a Bindwell partner or competitor, but they are the natural buyers (or acquirers) of any successful AI-discovery platform, because Bindwell's B2B framing [Y Combinator] presupposes that someone else carries a candidate through field trials and registration. The second layer is the cluster of AI-for-biology and AI-for-chemistry platforms that have emerged out of the pharmaceutical side of the market and could in principle retarget at agrochemicals; the captured research does not name specific firms in this layer that have made the agrochemical pivot. The third layer is the substitute technologies already discussed, biologicals and RNAi crop protection, which compete for the same R&D budget inside the incumbents.

Where Bindwell's defensible edge plausibly sits today is in two areas the research does support. The first is talent and conviction at a price point that incumbents struggle to match: two founders working full time on a foundation-model approach to agrochemistry, backed by Y Combinator and a syndicate including Paul Graham [TechCrunch, Nov 2025]. The second is the open-source posture exemplified by PLAPT on GitHub [GitHub], which acts as a recruiting and credibility surface in a field where most pharma-AI work is closed. Both edges are perishable: incumbents can hire, and an open-source model is, by definition, not itself the moat.

Where Bindwell is most exposed is the part of the value chain it does not own: field trials, residue studies, regulatory submissions, and grower distribution. A competitor (named or unnamed) that already sits inside an agrochemical major, or that wins a co-development contract with one, can move a molecule through that pipeline in a way a standalone platform cannot. The most plausible 18-month scenario is therefore a partnership-defined one. Winner if X: Bindwell announces a named co-development or licensing deal with a top-ten agrochemical company, validating the platform with a buyer whose dossier capability complements its discovery capability. Loser if Y: 18 months pass without a named partner, a published lead candidate, or a peer-reviewed benchmark, at which point the seed narrative will need a Series A story built on something other than founder velocity.

Data Accuracy: ORANGE -- No named competitors in the structured facts; analysis is segment-level and inferred from the company's stated B2B positioning.

Opportunity

PUBLIC

If Bindwell's foundation-model thesis works even partially, the prize is a seat at the table of an industry whose discovery economics have not been seriously rewritten in a generation.

The headline opportunity. The single largest outcome Bindwell could plausibly become is the default computational discovery layer for new crop-protection actives, the agrochemical analogue of what protein-structure prediction has become for early drug discovery. The cited evidence makes that outcome reachable rather than purely aspirational on three counts: the founders have shipped a working open-source binding-affinity model already used to anchor the company's technical credibility [GitHub]; they have attracted capital and a YC slot that signal third-party conviction in the thesis [TechCrunch, Nov 2025] [Y Combinator]; and the company's own framing of the problem as a compute-and-data problem rather than a chemistry-intuition problem aligns with where the broader AI-for-science field has been moving [Bindwell blog].

Growth scenarios.

Scenario What happens Catalyst Why it's plausible
Platform-to-incumbent licensing Bindwell signs one or more named co-development deals with a global agrochemical major, licensing access to the platform and sharing economics on resulting molecules A first announced partnership within 18 months of the seed Incumbents are actively shopping for AI discovery capability and Bindwell has visible technical artifacts and YC credibility [TechCrunch, Nov 2025] [GitHub]
Own-pipeline lead molecule Bindwell advances a self-discovered candidate active to early field trials, then partners or out-licenses for registration A disclosed lead candidate plus a named CRO or partner for trials The B2B framing [Y Combinator] does not preclude in-house lead generation, and the seed scale is consistent with funding early discovery work
Open-source-led category standard PLAPT and successor models become the default tooling for academic and industrial agrochemical screening, giving Bindwell a recruiting and data flywheel ahead of any commercial product Adoption signals on GitHub plus citations in published agrochemical AI work The open-source posture is already in place [GitHub] and mirrors the playbook used by several successful AI-for-science platforms

What compounding looks like. The flywheel for a platform like Bindwell is data and credibility. Each partnership or screening engagement, in principle, generates proprietary assay data that improves the next model; each open-source release attracts the kind of computational chemistry talent that closed pharma-AI shops compete hard for; and each published benchmark lowers the cost of the next business-development conversation with an incumbent. None of these loops is yet visible at scale in the captured sources, but PLAPT's existence on GitHub and the founders' willingness to discuss methodology publicly with outlets like Rowan are early indicators that the company intends to compete on credibility as well as on code [Rowan] [GitHub].

The size of the win. A credible numerical comparable is not in the captured sources, and this report will not invent one. Directionally, the agrochemical majors are public companies with multi-billion-dollar crop-protection segments, and a discovery platform that contributes even one commercial active to one of those pipelines participates in economics measured in hundreds of millions of dollars over a product's life (scenario, not a forecast). The narrower, nearer-term comparable is the wave of AI drug-discovery platforms that reached unicorn valuations on the strength of platform deals before any approved drug, a pattern Bindwell could mirror if scenario one above plays out within the seed-to-Series-A window.

Data Accuracy: YELLOW -- Headline opportunity and flywheel framing supported by TechCrunch, Y Combinator, the company blog, and GitHub; specific scale comparables are deliberately omitted absent a cited third-party figure.

Sources

PUBLIC

  1. [Bindwell] Bindwell company site | https://bindwell.ai/

  2. [Bindwell blog] Defeating pests with AI models: Our first-principles approach | https://bindwell.ai/posts/defeating-pests-with-ai

  3. [Y Combinator] Bindwell: Discovering new pesticides with AI | https://www.ycombinator.com/companies/bindwell

  4. [El Estoque, Jan 2025] Company founded by MVHS alum Tyler Rose '25 is accepted into Y Combinator | https://elestoque.org/2025/01/13/news/company-founded-by-mvhs-alum-tyler-rose-25-is-accepted-into-y-combinator/

  5. [Tracxn] Bindwell - 2025 Company Profile, Team, Funding & Competitors | https://tracxn.com/d/companies/bindwell/__1kajjKUJN0ZeqwmniVBPG1tKDv-En-3T59T1Iqj3a24

  6. [Crunchbase] Bindwell - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/bindwell

  7. [Rowan] A Conversation With Navvye Anand (Bindwell) | https://rowansci.com/blog/a-conversation-with-navvye-anand

  8. [LinkedIn] Navvye Anand - Founder @ Bindwell | YC W25 | Caltech | https://www.linkedin.com/in/navvye-anand/

  9. [TechCrunch, Nov 2025] Teen founders raise $6M to reinvent pesticides using AI, and convince Paul Graham to join in | https://techcrunch.com/2025/11/13/teen-founders-raise-6m-to-reinvent-pesticides-using-ai-and-convince-paul-graham-to-join-in/

  10. [Forbes] Bindwell company profile | https://www.forbes.com/profile/bindwell/

  11. [Forbes, 2026] Forbes 30 Under 30 2026: Youngest | https://www.forbes.com/30-under-30/2026/youngest/

  12. [HuntScreens] Bindwell: AI-Powered Pesticide R&D Platform | https://www.huntscreens.com/en/products/bindwell

  13. [Ventureport] How a Teen-Founded Startup Is Using AI to Reinvent Pesticide Discovery | https://www.ventureport.net/news/how-a-teen-founded-startup-is-using-ai-to-reinvent-pesticide-discovery

  14. [GitHub] Bindwell organization (PLAPT and related repositories) | https://github.com/Bindwell

Articles about Bindwell

View on Startuply.vc